SUNZEN BIOTECH BHD

KLSE: 0148 (SUNZEN)

最近更新时间: 18 Dec, 8:13PM

0.315

-0.01 (-1.56%)

前收盘价格 0.320
收盘价格 0.315
成交量 26,300
平均成交量 (3个月) 834,417
市值 246,215,968
市盈率 (P/E TTM) 31.50
价格/销量 (P/S) 2.95
股市价格/股市净资产 (P/B) 1.76
52周波幅
0.220 (-30%) — 0.400 (26%)
营业毛利率 6.33%
营业利益率 (TTM) 5.21%
稀释每股收益 (EPS TTM) 0.010
总债务/股东权益 (D/E MRQ) 5.11%
流动比率 (MRQ) 7.11
营业现金流 (OCF TTM) 9.82 M
资产报酬率 (ROA TTM) 4.93%
股东权益报酬率 (ROE TTM) 5.98%

市场趋势

短期 中期
行业 Packaged Foods (MY) 看涨 看涨
Packaged Foods (全球的) 混合的 混合的
股票 SUNZEN - -

AIStockmoo 评分

1.9
分析师共识 2.0
内部交易活动 NA
价格波动 2.0
技术平均移动指标 2.5
技术振荡指标 1.0
平均 1.88

相关股票

股票 市值 DY P/E(TTM) P/B
SUNZEN 246 M - 31.50 1.76
DLADY 2 B 1.65% 21.76 3.93
HUPSENG 952 M 5.88% 17.00 5.63
AJI 929 M 16.39% 2.23 1.15
KAWAN 573 M 4.19% 23.86 1.47
SDS 487 M 1.43% 13.22 3.44

Sunzen Biotech Bhd is engaged in the business of research and development of biotechnology and manufacturing and marketing of animal health products. The company operates in the business segments of Manufacturing and trading animal health products; Trading and processing of crude palm oil and related products; Traditional Chinese medicines and herbal health foods and beverages and loan financing. It generates key revenue from the Traditional Chinese medicines and herbal health foods and beverages segment.

部门 Consumer Defensive
行业 Packaged Foods
投资方式 Small Core
内部持股比例 55.78%

该时间范围内无数据。

该时间范围内无数据。

日期 类型 细节
27 Dec 2024 公告 SUNZEN - CHANGE OF NAME
19 Dec 2024 公告 Additional Listing Announcement /Subdivision of Shares
11 Dec 2024 公告 Additional Listing Announcement /Subdivision of Shares
11 Dec 2024 公告 Notice of SBB by a Company Pursuant to Section 127 (16) of CA 2016
09 Dec 2024 公告 Additional Listing Announcement /Subdivision of Shares
02 Dec 2024 公告 Additional Listing Announcement /Subdivision of Shares
28 Nov 2024 公告 Immediate Announcement on Shares Buy Back
27 Nov 2024 公告 Additional Listing Announcement /Subdivision of Shares
22 Nov 2024 公告 PROVISION OF FINANCIAL ASSISTANCE
22 Nov 2024 公告 Quarterly rpt on consolidated results for the financial period ended 30/09/2024
19 Nov 2024 公告 Additional Listing Announcement /Subdivision of Shares
08 Nov 2024 公告 Additional Listing Announcement /Subdivision of Shares
01 Nov 2024 公告 Additional Listing Announcement /Subdivision of Shares
30 Oct 2024 公告 Annual Report & CG Report - 2024
30 Oct 2024 公告 Part A: Share Buy-Back Statement in relation to the Proposed Renewal of Authority for Purchase of Own Shares by the Company Part B: Circular to Shareholders in relation to the Proposed Change of Company Name from "Sunzen Biotech Berhad" to "Sunzen Group Berhad"
29 Oct 2024 公告 General Meetings: Notice of Meeting
28 Oct 2024 公告 Additional Listing Announcement /Subdivision of Shares
22 Oct 2024 公告 Notice of Person Ceasing (Section 139 of CA 2016) - MADAM CHUM MUN CUAN
22 Oct 2024 公告 Additional Listing Announcement /Subdivision of Shares
21 Oct 2024 公告 Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR TEO YEK MING
21 Oct 2024 公告 Changes in Director's Interest (Section 219 of CA 2016) - MR TEO YEK MING
21 Oct 2024 公告 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
17 Oct 2024 公告 Additional Listing Announcement /Subdivision of Shares
14 Oct 2024 公告 SUNZEN BIOTECH BERHAD ("SUNZEN" OR "THE COMPANY") - PROPOSED RENEWAL OF AUTHORITY FOR PURCHASE OF OWN SHARES BY THE COMPANY ("THE PROPOSED RENEWAL OF SHARE BUY-BACK AUTHORITY")
14 Oct 2024 公告 Change of Company Name - SUNZEN GROUP BERHAD
11 Oct 2024 公告 Additional Listing Announcement /Subdivision of Shares
11 Oct 2024 公告 TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : NON RELATED PARTY TRANSACTIONS
10 Oct 2024 公告 Additional Listing Announcement /Subdivision of Shares
09 Oct 2024 公告 PROVISION OF FINANCIAL ASSISTANCE
04 Oct 2024 公告 Additional Listing Announcement /Subdivision of Shares
02 Oct 2024 公告 Additional Listing Announcement /Subdivision of Shares
02 Oct 2024 TheEdge Sunzen Biotech identifies another target for acquisition, deal may be reached next year
01 Oct 2024 公告 TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : NON RELATED PARTY TRANSACTIONS
01 Oct 2024 TheEdge MISC, MHB, PA Resources, Tanco, Ho Hup, Central Global, Sunzen Biotech, Aemulus, Pharmaniaga, Plenitude, Pasdec
30 Sep 2024 公告 TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : NON RELATED PARTY TRANSACTIONS
显示更多

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2024 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票